SGRY Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
815.3M
-4.0%
848.9M
+4.7%
810.9M
-8.4%
885.0M
+7.7%
821.5M
Cost of Revenue
0
0
0
0
0
Gross Profit
815.3M
-4.0%
848.9M
+4.7%
810.9M
-8.4%
885.0M
+7.7%
821.5M
Operating Expenses
729.5M
-2.8%
750.8M
+0.8%
744.9M
-3.4%
771.3M
+9.5%
704.1M
R&D
0
0
0
0
0
SG&A
379.6M
-3.2%
392.2M
+1.1%
388.0M
+1.8%
381.2M
+3.3%
369.2M
Operating Income
85.8M
-12.5%
98.1M
+48.6%
66.0M
-42.0%
113.7M
-3.2%
117.4M
EBITDA
148.4M
-4.7%
155.8M
+27.1%
122.6M
-36.6%
193.4M
+10.8%
174.6M
Net Income
14.1M
-52.5%
29.7M
+1514.3%
-2100000
-107.2%
29.0M
+14.6%
25.3M
EPS (Basic)
$-0.16
-33.3%
$-0.12
+57.1%
$-0.28
-133.3%
$-0.12
+33.3%
$-0.18
EPS (Diluted)
$-0.16
-33.3%
$-0.12
+57.1%
$-0.28
-133.3%
$-0.12
+33.3%
$-0.18
Shares (Diluted)
128.9M
+0.0%
128.8M
+0.4%
128.4M
+0.2%
128.0M
+0.7%
127.2M
Surgery Partners (SGRY) — Financials